Development of a disease-specific instrument to measure quality of life in patients with alopecia areata

European Journal of Dermatology

Volumn 22, Issue 4, 2012, Pages 531-536

  Endo, Yuichiro ^a   Miyachi, Yoshiki ^a   Arakawa, Akiko ^a,b,c  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF LÜBECK   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Alopecia areata; Disease specific; Outcome measure; Quality of life

Indexed keywords

ACCURACY; ADULT; ALOPECIA AREATA; ALOPECIA AREATA PATIENT QUALITY OF LIFE; ARTICLE; CLINICAL ASSESSMENT TOOL; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTERNAL CONSISTENCY; INTERVIEW; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SCORING SYSTEM; SELF REPORT; VALIDITY;

ADULT; ALOPECIA AREATA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 84865381588     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2012.1752     Document Type: Article

References (25)

1. Alkhalifah A, Alsantali A, Wang E et al. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010; 62: 177-88. quiz 89-90.
2. MacDonald Hull SP, Wood ML, Hutchinson PE, et al. Guidelines for the management of alopecia areata. Br J Dermatol 2003; 149: 692-9.
3. Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis 1989; 11: 954-63.
4. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997; 136: 305-14.
5. Skoet R, Zachariae R, Agner T. Contact dermatitis and quality of life: a structured review of the literature. Br J Dermatol 2003; 149: 452-6.
6. Fukuhara S, Suzukamo Y. Manual of the SF-8 Japanese Version. Kyoto: Institute for Health Outcome & Process Evaluation Research, 2004.
7. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-6.
8. Gupta MA, Gupta AK, Watteel GN. Stress and alopecia areata: a psychodermatologic study. Acta Derm Venereol 1997; 77: 296-8.
9. Wiebe S, Guyatt G, Weaver B, et al. Comparative responsiveness of generic and specific quality-of-life instruments. Journal of clinical epidemiology 2003; 56: 52-60.
10. Manolache L, Benea V. Stress in patients with alopecia areata and vitiligo. J Eur Acad Dermatol Venereol 2007; 21: 921-8.
11. Ruiz-Doblado S, Carrizosa A, Garcia-Hernandez MJ. Alopecia areata: psychiatric comorbidity and adjustment to illness. Int J Dermatol 2003; 42: 434-7.
12. Schmidt S, Fischer TW, Chren MM, et al. Strategies of coping and quality of life in women with alopecia. Br J Dermatol 2001; 144: 1038-43.
13. Dolte KS, Girman CJ, Hartmaier S, et al. Development of a health-related quality of life questionnaire for women with androgenetic alopecia. Clin Exp Dermatol 2000; 25: 637-42.
14. Marcoux D. Cosmetics, skin care, and appearance in teenagers. Semin Cutan Med Surg 1999; 18: 244-9.
15. Brajac I, Tkalcic M, Dragojevic DM, et al. Roles of stress, stress perception and trait-anxiety in the onset and course of alopecia areata. J Dermatol 2003; 30: 871-8.
16. Liakopoulou M, Alifieraki T, Katideniou A, et al. Children with alopecia areata: psychiatric symptomatology and life events. J Am Acad Child Adolesc Psychiatry 1997; 36: 678-84.
17. Picardi A, Pasquini P, Cattaruzza MS, et al. Psychosomatic factors in first-onset alopecia areata. Psychosomatics 2003; 44: 374-81.
18. Marsh W HK-T, Balla R, Grayson, D Is more ever too much? The number of indicators per factor in confirmatory factor analysis. Multivariate Behavioral Research 1998; 33: 181-220.
19. Iwata N, Mishima N, Shimizu T, et al. Positive and negative affect in the factor structure of the State-Trait Anxiety Inventory for Japanese workers. Psychol Rep 1998; 82: 651-6.
20. Olsen EA, Hordinsky MK, Price VH, et al. Alopecia areata investigational assessment guidelines-Part II. National Alopecia Areata Foundation. J Am Acad Dermatol 2004; 51: 440-7.
21. Bollen K. Structural equations with latent variables. New York: John Wiley & Sons, 1989.
22. Bentler PM MA. Choice of structural equation models via parsimony: a rational based on precision. Psychol Bull 1989; 106: 315-7.
23. Kondo-Endo K, Ohashi Y, Nakagawa H, et al. Development and validation of a questionnaire measuring quality of life in primary caregivers of children with atopic dermatitis (QPCAD). Br J Dermatol 2009; 161: 617-25.
24. Touw CR, Hakkaart-Van Roijen L, Verboom P, et al. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporin. Br J Dermatol 2001; 144: 967-72.
25. Bode RK, Heinemann AW, Butt Z, et al. Development and validation of participation and positive psychologic function measures for stroke survivors. Arch Phys Med Rehabil 2010; 91: 1347-56.